Low-dose CT scan 4-times more likely to detect malignant mass than x-ray

While traditional screenings for lung cancer include chest x-rays and sputum cytology, a low-dose computed tomography (CT) scan is the latest technology to identify small cancer growths before symptoms develop.

Scott Pierce, MD, who works at KentuckyOne Health Hematology and Oncology, notes this new screening is four times more likely to find a malignant mass than a traditional x-ray, leading to earlier detection and an increased rates of survival.

Read the full article: 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.